Reuters logo
BRIEF-China's Tasly Pharma, France's Pharnext plan JV in China
May 9, 2017 / 11:38 AM / 7 months ago

BRIEF-China's Tasly Pharma, France's Pharnext plan JV in China

May 9 (Reuters) - Tasly Pharmaceutical Group Co Ltd

* Says unit plans to invest 20 million euros ($21.79 million) in Pharnext S.A. For 12.6 percent stake

* Says it and Pharnext plan to invest 200 million yuan to set up JV in China for technology innovation and product development

Source text in Chinese: bit.ly/2pZjp8U

Further company coverage: ($1 = 0.9177 euros) (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below